Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment : a meta-analysis

Conference proceeding

Peer reviewed

M. C Nevitt, P Chen, D. P Kiel, J.-Y Reginster, R. K Dore, J. R Zanchetta, E. V Glass and J. H Krege

Osteoporosis international, Vol.17(11), pp.1630-1637

01/11/2006

PMID: 16896507

Abstract

Biological and medical sciences

Diseases of the osteoarticular system

Diseases of the spine

Medical sciences

Osteoporosis. Osteomalacia. Paget disease

1 Record Views

Title: Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment : a meta-analysis
Creators - without role: M. C Nevitt - University of California, San Francisco
P Chen - Eli Lilly
D. P Kiel - Hebrew SeniorLife
J.-Y Reginster - University of Liège
R. K Dore - Anaheim University
J. R Zanchetta - Instituto de Diagnóstico e Investigaciones Metabólicas
E. V Glass - Eli Lilly
J. H Krege - Eli Lilly
Publication Details: Osteoporosis international, Vol.17(11), pp.1630-1637
Publisher: Springer
Identifiers: 9947287808331
Academic Unit: King Saud University
Language: English
Resource Type: Conference proceeding